EYE
National Vision Holdings, Inc. NASDAQ$23.54
After hrs
$21.91
+0.00%
Mkt Cap $1.9B
52w Low $12.43
63.2% of range
52w High $30.02
50d MA $26.12
200d MA $26.13
P/E (TTM)
63.6x
EV/EBITDA
17.8x
P/B
2.1x
Debt/Equity
0.8x
ROE
3.4%
P/FCF
28.0x
RSI (14)
—
ATR (14)
—
Beta
1.40
50d MA
$26.12
200d MA
$26.13
Avg Volume
1.3M
About
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded s…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | AMC | 0.06 | 0.15 | +148.8% | 29.04 | -0.3% | +0.1% | -3.9% | -7.8% | -5.3% | -8.1% | -14.7% | — |
| Nov 5, 2025 | AMC | 0.12 | 0.13 | +8.3% | 24.70 | -0.4% | -4.9% | -2.3% | -2.3% | -2.3% | +0.2% | +18.5% | — |
| Aug 6, 2025 | AMC | 0.13 | 0.18 | +38.5% | 23.88 | +1.9% | +1.2% | -5.2% | -4.7% | -3.6% | -2.8% | -1.7% | — |
| May 7, 2025 | AMC | 0.29 | 0.34 | +17.2% | 15.61 | +2.4% | +6.9% | +10.0% | +20.2% | +20.8% | +19.3% | +34.7% | — |
| Feb 26, 2025 | AMC | -0.07 | -0.04 | +42.9% | 12.77 | +0.0% | -3.1% | -0.5% | -0.9% | -5.3% | -4.9% | +0.4% | — |
| Nov 6, 2024 | AMC | 0.05 | 0.12 | +140.0% | 11.89 | -0.4% | -2.2% | -3.2% | -0.6% | -5.0% | -6.9% | -5.6% | — |
| Aug 7, 2024 | AMC | 0.06 | 0.15 | +150.0% | 10.93 | -1.8% | +0.1% | -5.9% | -5.6% | -2.9% | -4.4% | -11.4% | — |
| May 8, 2024 | AMC | 0.28 | 0.30 | +7.1% | 14.90 | +1.3% | +1.7% | -0.9% | +0.3% | +2.6% | +7.4% | -3.2% | — |
| Feb 27, 2024 | AMC | -0.09 | -0.02 | +77.8% | 23.11 | -0.5% | -0.9% | +1.3% | +1.9% | +0.0% | -2.1% | -4.1% | — |
| Nov 9, 2023 | AMC | 0.06 | 0.15 | +150.0% | 17.34 | +1.8% | +6.3% | +0.1% | +10.8% | +12.5% | +10.3% | +9.7% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $29.04 | $28.95 | -0.3% | +0.1% | -3.9% | -7.8% | -5.3% | -8.1% |
| Mar 5 | UBS | Maintains | Buy → Buy | — | $29.04 | $28.95 | -0.3% | +0.1% | -3.9% | -7.8% | -5.3% | -8.1% |
| Mar 5 | Guggenheim | Maintains | Buy → Buy | — | $29.04 | $28.95 | -0.3% | +0.1% | -3.9% | -7.8% | -5.3% | -8.1% |
| Mar 5 | Citigroup | Maintains | Buy → Buy | — | $29.04 | $28.95 | -0.3% | +0.1% | -3.9% | -7.8% | -5.3% | -8.1% |
| Mar 5 | Barclays | Maintains | Overweight → Overweight | — | $29.04 | $28.95 | -0.3% | +0.1% | -3.9% | -7.8% | -5.3% | -8.1% |
| Mar 2 | Barclays | Maintains | Overweight → Overweight | — | $26.97 | $26.41 | -2.1% | -0.1% | -1.3% | +7.7% | +7.8% | +3.4% |
| Jan 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $28.51 | $28.62 | +0.4% | +3.2% | -1.8% | -4.6% | -4.6% | -6.1% |
| Nov 18 | Barclays | Maintains | Overweight → Overweight | — | $24.46 | $24.85 | +1.6% | +1.8% | +1.1% | +0.5% | +8.7% | +14.4% |
| Nov 18 | UBS | Maintains | Buy → Buy | — | $24.46 | $24.85 | +1.6% | +1.8% | +1.1% | +0.5% | +8.7% | +14.4% |
| Nov 18 | Citigroup | Maintains | Buy → Buy | — | $24.46 | $24.85 | +1.6% | +1.8% | +1.1% | +0.5% | +8.7% | +14.4% |
Recent Filings
Data updated apr 25, 2026 8:17am
· Source: massive.com